HIV+Hep in the News

;

Senate maintains HIV funding in spending bill, in contrast to House

by | Aug 2, 2024

Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, thanked Senate lawmakers for prioritizing the domestic response to HIV in a statement responding to their bipartisan vote Thursday (Aug. 1) to advance the bill. “However, given that the House version of the bill includes sizeable funding cuts, program eliminations, and divisive policy riders, we realize passage of this spending bill is far from reality. House Republicans must come to the table and support bills, such as this one, that can pass the Congress and be signed by the President,” Schmid said.

read more

‘We’ve watched her live in pain.’ Why some Sacramento families can’t afford needed medication

by | Jul 31, 2024

The problem is that insurance companies are not accepting copay assistance toward a patient’s deductible due to a practice known as a copay accumulator, according to Carl Schmid, executive director of the HIV + Hepatitis Policy Institute. “So insurers are taking the money, but they’re not applying it to the person’s out-of-pocket costs and their deductible,” Schmid said. “And then the insurers make the patient pay for the costs.”

read more

Federal HIV program set to wind down

by | Jul 23, 2024

One reason for the program’s low uptake, those advocates said, is that it only covered the costly PrEP medication but not the doctor visits or blood work necessary for a prescription. It also did not include funding for outreach or education about the drug. “It just proves that it’s not just the price of the drug, it’s all the other services that go with PrEP,” Carl Schmid, president of the HIV+Hepatitis Policy Institute, said. “You need a doctor to provide the drug, you need the labs — that was the failure.”

read more

Search

Pin It on Pinterest

Share This